152 related articles for article (PubMed ID: 10578478)
1. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
Herbert BS; Sanders BG; Kline K
Nutr Cancer; 1999; 34(2):121-32. PubMed ID: 10578478
[TBL] [Abstract][Full Text] [Related]
2. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
[TBL] [Abstract][Full Text] [Related]
3. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells.
Yu W; Heim K; Qian M; Simmons-Menchaca M; Sanders BG; Kline K
Nutr Cancer; 1997; 27(3):267-78. PubMed ID: 9101557
[TBL] [Abstract][Full Text] [Related]
4. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
[TBL] [Abstract][Full Text] [Related]
5. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1.
Yu W; Sanders BG; Kline K
Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
7. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
Charpentier A; Simmons-Menchaca M; Yu W; Zhao B; Qian M; Heim K; Sanders BG; Kline K
Nutr Cancer; 1996; 26(2):237-50. PubMed ID: 8875561
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
9. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
10. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
11. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
12. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
Torrisi R; Pensa F; Orengo MA; Catsafados E; Ponzani P; Boccardo F; Costa A; Decensi A
Cancer Res; 1993 Oct; 53(20):4769-71. PubMed ID: 8402658
[TBL] [Abstract][Full Text] [Related]
13. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide.
Pellegrini R; Mariotti A; Tagliabue E; Bressan R; Bunone G; Coradini D; Della Valle G; Formelli F; Cleris L; Radice P
Cell Growth Differ; 1995 Jul; 6(7):863-9. PubMed ID: 7547508
[TBL] [Abstract][Full Text] [Related]
14. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
15. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
Simeone AM; Deng CX; Kelloff GJ; Steele VE; Johnson MM; Tari AM
Carcinogenesis; 2005 May; 26(5):1000-7. PubMed ID: 15695235
[TBL] [Abstract][Full Text] [Related]
16. Cell death induced by N-(4-hydroxyphenyl)retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma.
Davies M; Paterson IC; Ganapathy A; Prime SS
Int J Cancer; 2006 Dec; 119(12):2803-11. PubMed ID: 17044020
[TBL] [Abstract][Full Text] [Related]
17. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
Shan D; Gopal AK; Press OW
Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831
[TBL] [Abstract][Full Text] [Related]
19. Defective TGF-beta signaling sensitizes human cancer cells to rapamycin.
Gadir N; Jackson DN; Lee E; Foster DA
Oncogene; 2008 Feb; 27(8):1055-62. PubMed ID: 17700525
[TBL] [Abstract][Full Text] [Related]
20. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells.
Yang X; Hao Y; Ding Z; Pater A
Exp Cell Res; 2000 May; 256(2):491-9. PubMed ID: 10772821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
